Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, GUIDED THERAPEUTICS, INC. reported revenue of $1M, up 10857.1% year over year. Operating margin was -309.3% and net margin -416.7%, on a free-cash-flow margin of -139.5% with capital expenditure at 0.3% of revenue. Every figure is computed directly from GTHP's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $1M | -309.3% | -416.7% |
| FY2024 | $0M | -30114.3% | -34528.6% |
| FY2023 | $0M | -3527.6% | -3560.2% |
| FY2022 | $0M | -25638.5% | -33392.3% |
| FY2021 | $0M | -2916.0% | -2555.6% |
How does GTHP compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.